mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.3 |
mRNA |
spautin-1 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.3 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.3 |
mRNA |
BRD4132 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.4 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.4 |
mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
-0.041 |
0.4 |
mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
-0.046 |
0.4 |